Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen

RATIONALE: Pulmonary sarcomatoid carcinoma (PSC) represents <1% of all lung cancers and is characterized by a very poor prognosis. The optimal therapeutic regimen remains unclear. We describe a rare case of PSC with both anaplastic lymphoma kinase (ALK)-arranged and high levels of programmed deat...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Antonio, Federica, De Sanctis, Rita, Bolengo, Isabella, Destro, Annarita, Rahal, Daoud, De Vincenzo, Fabio, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708868/
https://www.ncbi.nlm.nih.gov/pubmed/31393391
http://dx.doi.org/10.1097/MD.0000000000016754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708868/
https://www.ncbi.nlm.nih.gov/pubmed/31393391
http://dx.doi.org/10.1097/MD.0000000000016754

Ejemplares similares